BriaCell Therapeutics Corp. Common Shares (NASDAQ: BCTX)
$0.7700
+0.1680 ( +24.50% ) 3.0M
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.
Market Data
Open
$0.7700
Previous close
$0.6023
Volume
3.0M
Market cap
$21.79M
Day range
$0.6050 - $0.7910
52 week range
$0.4641 - $5.9700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 24 | Jun 14, 2024 |
| 4 | Insider transactions | 1 | May 20, 2024 |
| 8-k | 8K-related | 26 | May 17, 2024 |
| 8-k | 8K-related | 24 | Apr 02, 2024 |
| 10-q | Quarterly Reports | 59 | Mar 18, 2024 |
| 8-k | 8K-related | 15 | Jan 31, 2024 |
| def | Proxies and info statements | 9 | Jan 09, 2024 |
| 8-k | 8K-related | 15 | Dec 20, 2023 |
| 10-q | Quarterly Reports | 54 | Dec 14, 2023 |
| 8-k | 8K-related | 23 | Dec 14, 2023 |